INTRODUCTION
============

Chloride is the primary anion in the extracellular fluid. The chloride concentration differs in different compartments and cell types, and the concentrations in the plasma (\[Clâ€\"\]~plasma~) and interstitial fluid are approximately 105 and 117mmol/L, respectively. The intracellular chloride ion concentration is low because of the presence of other anions, such as DNA, RNA, proteins, and phosphate. Three major mechanisms that determine the homeostasis of chloride include input through digestive or parenteral routes, output primarily through the urine and secondarily by the feces, and the ion shift among body compartments.^([@r01])^

The evaluation of \[Cl^-^\]~plasma~ is a key step in the analysis of the acid-base status of critically ill patients. Chloride is a strong anion; therefore, its changes modify the strong ion difference in the plasma (\[SID\]~plasma~). According to the Stewart approach, the \[SID\]~plasma~ is an independent variable that induces changes in the dissociation of water and, as a consequence, changes in pH.^([@r02])^ Examples of these alterations are hyperchloremic metabolic acidosis and hypochloremic metabolic alkalosis.

Hyperchloremic metabolic acidosis is a common condition in postoperative patients. Despite the lack of definitive evidence, experimental and clinical studies suggest that this disorder produces deleterious effects.^([@r03]-[@r07])^ The pathogenesis of hyperchloremic metabolic acidosis is often attributed to the infusion of large amounts of saline solutions that have supraphysiological concentrations of chloride.^([@r08],[@r09])^ Another major mechanism that could theoretically contribute to the development of this condition is the elimination of chloride in the urine. An inadequate renal response in the face of a chloride load could facilitate the development or perpetuate the occurrence of hyperchloremia over time. Although critically ill patients with metabolic acidosis frequently exhibit an abnormal renal response,^([@r10])^ this mechanism has not yet been assessed as a determinant of postoperative hyperchloremia.

Our goal was to evaluate the determinants of \[Cl^-^\]~plasma~ during the first postoperative day, especially with respect to the relationship between strong ion input through intravenous fluids and strong ion output by the kidneys. Our hypothesis was that the modifications in \[Cl^-^\]~plasma~ are largely dependent on the behavior of the urinary strong ion difference (\[SID\]~urine~=\[Na^+^\]~plasma~+\[K^+^\]~plasma~-\[Cl^-^\]~urine~) and not on differences in the fluids administered.

METHODS
=======

This was a prospective cohort study conducted in a teaching intensive care unit. We included consecutive patients admitted during the immediate postoperative period over ten months. Patients with renal failure (serum creatinine levels \>1.7mg/dL) or bladder irrigation, patients without urinary catheterization, and patients with incomplete data were excluded.

Our study was approved by the Institutional Review Board (\#17,032,010). Standard procedures were applied in the diagnosis; thus, only permission to use these data was requested from patients or relatives.

Measurements
------------

At intensive care unit (ICU) admission, demographic data (age, gender), the Acute Physiology and Chronic Health Evaluation II (APACHE II) score,^([@r11])^ the predicted risk of mortality, and the Sequential Organ Failure Assessment (SOFA) score^([@r12])^ were calculated. Arterial blood samples were analyzed for gases (AVL OMNI 9, Roche Diagnostics, Graz, Austria); strong ion concentrations, including \[Na^+^\], \[K^+^\] and \[Cl^-^\] (selective electrode ion, AEROSET, Abbott Laboratories, Abbott Park, Illinois, U.S.A.); \[Ca^++^\] (selective electrode ion, AVL OMNI 9), \[Mg^++^\] (Arsenazo dye/Mg complex); \[albumin\] (Bromcresol-sulfonphthaleinyl); \[Pi^-^\] (molybdate-vanadate); and \[lactate\] (selective electrode ion, AVL OMNI 9). \[Na^+^\], \[K^+^\] and \[Cl^-^\] were also measured in the urine. These measurements were repeated 24 hours later. The volume and characteristics of the fluids administered during the surgery and the first postoperative day were also recorded.

We calculated the \[HCO~3~^-^\] and extracellular base excess (\[BE\]) using the Henderson-Hasselbalch^([@r13],[@r14])^ and Van Slyke equations.^([@r15],[@r16])^ The plasma anion gap (\[AG\]) was calculated as \[AG\]=(\[Na^+^\]+\[K^+^\])-(\[Cl^-^\]+\[HCO~3~ ^-^\])^([@r17])^ and was corrected for the effects of an abnormal albumin concentration:^([@r18])^\[AG\]~corrected~ (mmol/L)=\[AG\]~observed~+0.25 \* (\[normal albumin\] - \[observed albumin\])(in g/L). The \[SID\]~urine~ was calculated as \[SID\]~urine~=(\[Na^+^\]~urine~+\[K^+^\]~urine~)-\[Cl^-^\]~urine~,^(10)^and the \[SID\] effective was calculated as \[SID\]~effective~=\[HCO~3~ ^-^\]+\[albumin^-^\]+\[Pi^-^\].^([@r19])^ Normal values of \[SID\]~effective~ are 40±2mmol/L.^([@r20])^ The apparent \[SID\] was calculated as \[SID\]~apparent~=\[Na^+^\]+\[K^+^\]+\[Ca^++^\]+\[Mg^++^\]-\[Cl^-^\].^([@r20])^ The \[albumin^-^\] (g/L) and \[Pi^-^\] (mmol/L) were calculated based on measured values and pH using the following equations: \[albumin^-^\]=\[albumin\] \* (0.123 \* pH-0.631) and \[Pi^-^\]=\[Pi\] \* (0.309 \* pH-0.469), respectively.^([@r19])^The strong ion gap (\[SIG\]) consists of strong anions other than \[Cl^-^\], including lactate, ketoacids and other organic anions, and sulfate, and was calculated as \[SIG\]=\[SID\]~apparent~-\[SID\]~effective~.^([@r19])^ We adjusted the \[Cl^-^\] and \[SIG\] for water excess/deficit by multiplying the observed value by a correcting factor (\[Na^+^\]~normal~/\[Na^+^\]~observed~).^([@r19])^ Normal values of \[SIG\] are 2±2mmol/L.^([@r20])^

Data analysis
-------------

Patients were assigned to one of three groups according to their variation in \[Cl^-^\]~plasma~ over the 24 hours period: increased \[Cl^-^\]~plasma~ (increase ≥2mmol/L), decreased \[Cl^-^\]~plasma~ (decrease ≥2mmol/L), and unchanged \[Cl^-^\]~plasma~ (change \<2mmol/L).

A normal distribution was confirmed using the Kolmogorov-Smirnov test. One-way or two-way repeated measures ANOVA followed by post-hoc tests was used to identify specific differences between and within groups. A multiple linear regression analysis was performed to identify independent predictors of the 24 hours \[Cl^-^\]~plasma~ variation. A p value \<0.05 was considered significant.

RESULTS
=======

A total of 220 patients were screened. Out of these patients, 148 of them were included, and 72 were excluded because of serum creatinine levels \>1.7mg/dL (n=11), bladder irrigation (n=20), a lack urinary catheterization (n=23), incomplete data registration (n=15), or death during the study period (n=3).

The \[Cl^-^\]~plasma~ increased in 39 patients, decreased in 56, and remained unchanged in 53. [Table 1](#t01){ref-type="table"} summarizes the epidemiologic and clinical conditions of the patients. There were no differences in the plasma creatinine levels among the three groups. The 24 hours changes in creatinine plasma concentration were 0.0±0.2, 0.0±0.3, and -0.1±0.4 in the increased \[Cl^-^\]~plasma~, decreased \[Cl^-^\]~plasma~, and unchanged \[Cl^-^\]~plasma~ groups, respectively (p=NS). The percentages of patients who met the criterion for stage 1 of the AKIN classification (increase in the plasma creatinine concentration ≥0.3mg%) were 10, 14, and 15%, respectively (p=NS).

###### 

Epidemiological and clinical data

                                                                         **Increased**   **Decreased**   **Unchanged**
  ---------------------------------------------------------------------- --------------- --------------- ---------------
  N                                                                      39              56              53
  Gender, male                                                           16 (41)         23 (39)         23 (43)
  Age (years)                                                            68±18\*         61±16           61±16
  APACHE II score                                                        11±5\*          9±5             8±4
  SOFA score                                                             3±3\#           2±2             1±2
  ICU mortality                                                          8               2               4
  Actual hospital mortality                                              10              2               4
  ICU length of stay (days)                                              5±7             6±8             3±3\*
  Hospital length of stay (days)                                         12±10           13±9            9±6\*
  Mechanical ventilation^a^                                              8 (21)          6 (11)          5 (9)
  Type of surgery                                                                                         
      Gastrointestinal                                                   20 (51)         28 (50)         28 (53)
      Orthopedic                                                         5 (13)          8 (14)          14 (26)
      Neurosurgery                                                       2 (5)           5 (9)           3 (6)
      Obstetric/gynecologic                                              5 (13)          2 (4)           3 (6)
      Thoracic                                                           2 (5)           10 (18)         4 (8)
      Urologic                                                           5 (13)          3 (5)           1 (2)
      Oncologic                                                          12 (31)         22 (39)         14 (26)
      Emergency                                                          11 (28)         30 (54)         23 (43)
  Shock^b^                                                               8 (21)          10 (18)         6 (11)
  Blood urea (mg/dL)                                                     42±22           34±17           36±13
  Plasma creatinine (mg/dL)                                              1.1±0.7         0.9±0.3         1.0±0.4
  Furosemide use                                                         5 (13)          7 (13)          3 (6)
  Fluids administered during surgery (L)                                 1.783±1.070     2.552±1.616\*   2.052±1.056
  Strong-ion difference of fluids administered during surgery (mmol/L)   1±2\*           6±11            6±8

APACHE II - Acute Physiology and Chronic Health Evaluation II; SOFA - Sequential Organ Failure Assessment; ICU - intensive care unit. ^a^ Mechanical ventilation at any moment during the first postoperative day; ^b^ shock during surgery or on ICU admission. ^\*^ p\<0.05 versus the other groups; ^\#^ p\<0.05 versus the unchanged \[Cl^-^\]~plasma~ group. The results are expressed as the mean and standard deviation or number and percentage.

On admission, the increased \[Cl^-^\]~plasma~, decreased \[Cl^-^\]~plasma~, and unchanged \[Cl^-^\]~plasma~ groups showed similar plasma values for pH (7.34±0.07, 7.33±0.06, and 7.33±0.05, respectively), PCO~2~ (37±7, 39±7, and 39±6mmHg, respectively), \[HCO~3~ ^-^\] (19±3, 20±3, and 20±2mmol/L, respectively), \[BE\] (-6±4, -5±3, and -5±2mmol/L, respectively), and \[SID\]~plasma~ (30±4, 31±4, and 31±3mmol/L, respectively). The increased \[Cl^-^\]~plasma~ group had a lower \[Cl^-^\]~plasma~ ([Figure 1](#f01){ref-type="fig"}) and a higher \[AG\] (22±5, 18±4, and 20±4mmol/L, p\<0.05) and \[SIG\] (11±5, 6±5, and 8±4mmol/L, p\<0.05) when compared with the other groups.

![Variation in the plasma chloride concentration in the increased \[Cl^-^\]~plasma~, decreased \[Cl^-^\]~plasma~, and unchanged \[Cl^-^\]~plasma~ groups. ICU - intensive care unit.](rbti-25-03-0197-g01){#f01}

After 24 hours, no differences were found in the pH (7.36±0.08, 7.38±0.05, and 7.39±0.04), \[HCO~3~ ^-^\] (21±4, 22±3, and 23±2mmol/l), \[BE\] (-4±5, -3±3, and -2±2mmol/L), and \[SID\]~plasma~ (31±5, 32±3, and 33±3mmol/L) among the increased \[Cl^-^\]~plasma~, decreased \[Cl^-^\]~plasma~, and unchanged \[Cl^-^\]~plasma~ groups. The increased \[Cl^-^\]~plasma~ group exhibited a higher \[Cl^-^\]~plasma~ and a lower \[AG\] (15±5, 21±5, and 17±4mmol/L, p\<0.05) and \[SIG\] (4±5, 10±5, and 6±4mmol/L, p\<0.05) when compared with the other groups ([Table 2](#t02){ref-type="table"} and [Figure 1](#f01){ref-type="fig"}). After 24 hours, the arterial pH and \[BE\] improved in the decreased and unchanged \[Cl^-^\]~plasma~ groups but not in the increased \[Cl^-^\]~plasma~ group ([Table 2](#t02){ref-type="table"}). Accordingly, the 24 hours change in pH (0.03±0.07 versus 0.06±0.07 and 0.05±0.06, p\<0.05) and \[BE\] (0.8±4 versus 3±3 and 3±2mmol/L, p\<0.05) was lower in the increased \[Cl^-^\]~plasma~ group than in the other two groups.

###### 

Acid-base variables at admission and after 24 hours in the increased, decreased, and unchanged \[Cl^-^\]~plasma~ groups

                                              **Group**                     **On admission**   **24 hours**
  ------------------------------------------- ----------------------------- ------------------ --------------
  pH                                          Increased \[Cl^-^\]~plasma~   7.34±0.07          7.36±0.08
  Decreased \[Cl^-^\]~plasma~                 7.33±0.06                     7.38±0.05\*        
  Unchanged \[Cl^-^\]~plasma~                 7.33±0.05                     7.39±0.04\*        
  PCO~2~ (mmHg)                               Increased \[Cl^-^\]~plasma~   37±7               37±7
  Decreased \[Cl^-^\]~plasma~                 39±7                          37±5\*             
  Unchanged \[Cl^-^\]~plasma~                 39±6                          38±5\*             
  HCO~3~- (mmol/L)                            Increased \[Cl^-^\]~plasma~   19±3               21±4\*
  Decreased \[Cl^-^\]~plasma~                 20±3                          22±3\*             
  Unchanged \[Cl^-^\]~plasma~                 20±2                          23±2\*             
  Base excess (mmol/L)                        Increased \[Cl^-^\]~plasma~   -6±4               -4±5\*
  Decreased \[Cl^-^\]~plasma~                 -5±3                          -3±3\*             
  Unchanged \[Cl^-^\]~plasma~                 -5±2                          -2±2\*             
  Anion gap~corrected~ (mmol/L)               Increased \[Cl^-^\]~plasma~   22±5§              15±5\*
  Decreased \[Cl^-^\]~plasma~                 18±4§                         21±5\*§            
  Unchanged \[Cl^-^\]~plasma~                 20±4§                         17±4\*             
  Strong-ion difference~effective~ (mmol/L)   Increased \[Cl^-^\]~plasma~   30±4               31±5\*
  Decreased \[Cl^-^\]~plasma~                 31±4                          32±3\*             
  Unchanged \[Cl^-^\]~plasma~                 31±3                          33±3\*             
  Strong-ion gap~corrected~(mmol/L)           Increased \[Cl^-^\]~plasma~   11±5§              4±5\*
  Decreased \[Cl^-^\]~plasma~                 6±5§                          10±5\*§            
  Unchanged \[Cl^-^\]~plasma~                 8±4§                          6±4\*              
  Non-volatile weak anions (mmol/L)           Increased \[Cl^-^\]~plasma~   11±2               10±2
  Decreased \[Cl^-^\]~plasma~                 11±2                          10±2               
  Unchanged \[Cl^-^\]~plasma~                 11±2                          11±2               
  Albumin (g%)                                Increased \[Cl^-^\]~plasma~   3.2±0.6            3.0±0.6
  Decreased \[Cl^-^\]~plasma~                 3.4±0.6                       3.2±0.5            
  Unchanged \[Cl^-^\]~plasma~                 3.2±0.7                       3.1±0.6            
  Phosphate (mg%)                             Increased \[Cl^-^\]~plasma~   3.6±1.2            3.0±1.1\*
  Decreased \[Cl^-^\]~plasma~                 3.6±0.8                       2.8±0.7\*          
  Unchanged \[Cl^-^\]~plasma~                 3.3±1.1                       2.9±0.9\*          
  Lactate (mmol/L)                            Increased \[Cl^-^\]~plasma~   2.3±1.4            1.8±0.9\*
  Decreased \[Cl^-^\]~plasma~                 1.9±0.9                       1.6±0.9\*          
  Unchanged \[Cl^-^\]~plasma~                 2.1±1.3                       1.5±0.8\*          

p\<0.05 on admission versus 24 hours; ^§^ p\<0.05 versus the other groups. The results expressed as the mean and standard deviation.

The crystalloid solutions administered during surgery and the first 24 hours in the ICU were normal saline (77% of the total volume use) and Ringer lactate (23%). Colloid solutions were not used. During surgery, the increased \[Cl^-^\]~plasma~ group received a smaller volume of fluids with a lower \[SID\] than the decreased \[Cl^-^\]~plasma~ group ([Table 1](#t01){ref-type="table"}). In the ICU, the volume and \[SID\] of the fluids administered were similar among the three groups, but the 24 hours \[SID\]~urine~ was higher in the increased-\[Cl^-^\]~plasma~ group ([Figure 2](#f02){ref-type="fig"}). The fluid balance was similar in all three groups (2,405±2,475, 2,235±2,099, 1,872±1,405mL/24 hours, p=NS). The volume (6,160±2,382, 6,887±3,155, 5,912±1,706mL, p=NS) and \[SID\] (6±5, 6±6, 6±4mmol/L, p=NS) of the fluids administered during the perioperative period (surgery and the first 24 hours in the ICU) were similar.

![Volumes and strong ion differences of the administered solutions and urine in the increased \[Cl^-^\]~plasma~, decreased \[Cl^-^\]~plasma~, and unchanged \[Cl^-^\]~plasma~ groups. Panel A: Volume of the administered solutions. Panel B: Strong ion difference of the administered solutions. Panel C: Volume of diuresis. Panel D: 24 hours urine strong ion difference. SID - strong ion difference.](rbti-25-03-0197-g02){#f02}

A multiple linear regression analysis showed that the \[Cl^-^\]~plasma~ at admission and \[SID\]~urine~ were independent predictors of the 24 hours variation in \[Cl^-^\]~plasma~ ([Table 3](#t03){ref-type="table"}).

###### 

Multiple linear regression analysis of 24 hours changes with \[Cl^-^\]~plasma~ as the dependent variable

  **Independent variable**             **Coefficient**   **SE**   **t**   **p value**   **\[95% CI\]**
  ------------------------------------ ----------------- -------- ------- ------------- ----------------
  \[Cl^-^\]~plasma~ at ICU admission   0.523             0.085    6.14    \<0.0001      0.354-0.691
  24 hours \[SID\]~urine~              -0.0365           0.014    -2.64   0.009         0.064-0.009

SE - standard error; 95% CI - 95% confidence intervals; ICU - intensive care unit. Coefficient, partial regression coefficient. The square of the coefficient of multiple correlation (R^2^) in this model=0.26.

DISCUSSION
==========

That the changes in \[Cl^-^\]~plasma~ during the first postoperative day are related to the behavior of \[SID\]~urine~ and not to the differences in either the volume or the \[SID\] of the fluids administered constitutes the main finding of this study. This result suggests that the renal ability to decrease the \[SID\]~urine~ is a major mechanism for avoiding postoperative hyperchloremia. Nevertheless, other processes may also be involved in the regulation of \[Cl^-^\]~plasma~ because the \[Cl^-^\]~plasma~ on admission was also an independent determinant of the 24 hours variation in \[Cl^-^\]~plasma~.

Hyperchloremic metabolic acidosis is commonly found in surgical patients after volume expansion with saline solution. Moreover, a recent study showed that a restriction in the administration of chloride-rich fluids in critically ill patients decreased the incidence of both metabolic acidosis and hyperchloremia.^([@r21])^ The patients included in our study received hyperchloremic solutions with a low \[SID\] during the surgical procedure and thereafter in the ICU. Consequently, 28% of them were admitted to the ICU with hyperchloremia (defined as \[Cl^-^\]~plasma~ ≥110mmol/L), while a further 16% developed hyperchloremia within the next 24 hours (data not shown).

Although the Stewart approach has the same prognostic and diagnostic capabilities as the conventional analysis of acid-base metabolism,^([@r20])^ this alternative method can provide a better understanding of the underlying mechanisms of saline-induced metabolic acidosis.^([@r02],[@r22])^ According to the Stewart approach, the proton concentration is independently determined by the volatile and nonvolatile weak acids and by the \[SID\]. The \[SID\] is the difference between the sums of all the strong (i.e., fully dissociated, chemically nonreactive) cations and anions, such as \[Na^+^\], \[K^+^\], \[Ca^++^\], \[Mg^++^\], and \[Cl^-^\]. Changes in \[Cl^-^\]~plasma~ induced by the administration of fluids with chloride levels in excess of the sodium content will decrease the \[SID\] and increase the dissociation of water, producing acidosis.

In critically ill patients, hyperchloremia can also result from a physiological compensation for hypoalbuminemia. Capillary leakage and partial alteration of the Donan equilibrium with the diffusion of albumin from the intravascular space can result in a shift in chloride from the interstitial space to balance the loss of negative charge.^([@r23])^ In addition, Wilkes showed that the loss of weak acids secondary to hypoproteinemia is counteracted by a renal-mediated increase in \[Cl^-^\]~plasma~ to decrease the \[SID\].^([@r24])^ However, albumin and nonvolatile weak anions were similar among our three patient groups over the 24 hours evaluation period.

Another mechanism that could explain the development of hyperchloremia is the renal handling of chloride. The kidney plays a central role in the regulation of \[SID\]~plasma~ by modulating the urinary excretion and reabsorption of strong ions, such as sodium, potassium, and chloride. However, few studies have investigated the interactions between \[SID\]~urine~ and \[SID\]~plasma~. In patients with metabolic alkalosis, changes in \[SID\]~urine~ induced by the administration of acetazolamide account for the alterations in \[SID\]~plasma~.^([@r25])^ In a series of 98 critically ill patients with simple metabolic acidosis, a shift in the \[SID\]~urine~ to negative values was associated with a higher \[SID\]~plasma~ and a less severe acidemia when compared with patients that had a more positive \[SID\]~urine~.^([@r10])^ As a result, patients with a positive \[SID\]~urine~ showed higher \[Cl^-^\]~plasma~. These observations indicate that an inappropriate renal response may facilitate the development of hyperchloremia.

In the present study, all groups of patients received equivalent amounts of fluids and electrolytes. Nevertheless, the changes in \[Cl^-^\]~plasma~ varied significantly. We found that the main determinant of \[Cl^-^\]~plasma~ was the \[SID\]~urine~. The variation in the \[SID\]~urine~ may have been triggered by the characteristics of the metabolic acidosis that the patients presented with at admission to the ICU. Despite similar pH values, the acidosis was largely due to unmeasured anions in the increased \[Cl^-^\]~plasma~ group and by hyperchloremia in the decreased \[Cl^-^\]~plasma~ group. The different types of metabolic acidosis observed cannot be explained by the administration of fluids during the surgery. In fact, the increased \[Cl^-^\]~plasma~ group (i.e., those patients with the lower \[Cl^-^\]~plasma~, and the higher \[AG\] and \[SIG\] levels on admission) received fluids with a lower \[SID\]. The incidence of shock was also similar among the three groups.

Even though the cause remains unclear, the different types of metabolic acidosis on admission could have determined the subsequent renal handling of chloride. In fact, \[Cl^-^\]~plasma~ on admission was an independent predictor of the changes in \[Cl^-^\]~plasma~. As shown by the higher \[SID\]~urine~, the unmeasured anion acidosis in the increased \[Cl^-^\]~plasma~ group was associated with a decreased ability to eliminate chloride. We speculate that the renal excretion of nonabsorbable anions and sodium reduced the magnitude of the decrease in \[SID\]~urine~. In contrast, the decreased \[Cl^-^\] group, exhibited hyperchloremic metabolic acidosis and displayed an improved ability to eliminate chloride and decrease the \[SID\]~urine~. These effects may be due to the excretion of chloride with ammonium (a weak cation) and not sodium.

A potentially confounding condition was the use of furosemide. This drug decreases the \[SID\]~urine~ and induces metabolic alkalosis. Nevertheless, the furosemide in the study was used similarly in only few patients across the different groups.

The relevance of hyperchloremic metabolic acidosis as an independent predictor of outcome in critically ill patients has been the subject of intense discussion.^([@r06],[@r07],[@r26],[@r27])^ Our study demonstrated the presence of a more severe underlying disease, as shown by a higher APACHE-II score, in patients with increased \[Cl^-^\]~plasma~. Therefore, the lack of an adequate response in the face of a chloride load could constitute another manifestation of a more severe condition. We have previously shown that the failure to decrease \[SID\]~urine~ is a common feature in critically ill patients with metabolic acidosis and could be the expression of a form of renal dysfunction.^([@r10])^ In our former study, patients with an abnormal response of \[SID\]~urine~ had higher APACHE-II and SOFA scores and a more severe degree of metabolic acidosis.

Our present study has certain limitations. We decided to group patients according to the \[Cl^-^\]~plasma~ trend observed during the first 24 hours in the ICU because these first measurements were heterogeneous. However, this pattern may have been influenced by unevaluated factors. In addition, we only studied patients during the postoperative period. The basal data prior to surgery and a comprehensive evaluation of the fluid balance and output during the surgery were unavailable because the \[SID\]~urine~ was not measured during that period. Last, this observational study did not address the underlying mechanisms responsible for the different response patterns of the \[SID\]~urine~.

CONCLUSIONS
===========

Although the volume and the composition of fluids administered during the first postoperative day were similar between patients with opposite behaviors of \[Cl^-^\]~plasma~, the \[SID\]~urine~ was higher in patients who developed hyperchloremia. Our results suggest that the ability to decrease \[SID\]~urine~ is a major mechanism for avoiding saline-induced hyperchloremia. In addition, other mechanisms, such as the type of metabolic acidosis, may also act as relevant determinants of \[Cl^-^\]~plasma~.
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